{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T20:59:34Z","timestamp":1795208374998,"version":"4.10.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Progetti di Ricerca di Ateneo PRA 2015 of the University of Pisa."}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ijpharm.2016.11.020","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T12:00:48Z","timestamp":1478692848000},"page":"45-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["Ionic liquids as potential enhancers for transdermal drug delivery"],"prefix":"10.1016","volume":"516","author":[{"given":"Daniela","family":"Monti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Egiziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susi","family":"Burgalassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Chetoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Chiappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Sanzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Tampucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2016.11.020_bib0005","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1039\/b923855g","article-title":"In search of pure liquid salt forms of aspirin: ionic liquid approaches with acetylsalicylic acid and salicylic acid","volume":"12","author":"Bica","year":"2010","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0010","first-page":"528","article-title":"Technologies in transdermal drug delivery system: a review","volume":"3","author":"Biradar","year":"2014","journal-title":"Int. J. Pharm. Chem. Sci."},{"issue":"5","key":"10.1016\/j.ijpharm.2016.11.020_bib0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.4103\/0378-6323.162328","article-title":"Recent advances in topical formulation carriers of antifungal agents","volume":"81","author":"Bseiso","year":"2015","journal-title":"Ind. J. Dermatol. Venereol. L eprol."},{"issue":"1","key":"10.1016\/j.ijpharm.2016.11.020_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/02713683.2010.523193","article-title":"Arabinogalactan as Active Compound in the Management of Corneal Wounds: In Vitro Toxicity and In Vivo Investigations on Rabbits","volume":"36","author":"Burgalassi","year":"2011","journal-title":"Curr. Eye Res."},{"issue":"4","key":"10.1016\/j.ijpharm.2016.11.020_bib0025","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3109\/08982100903014994","article-title":"Span( and Tween( neutral and pH-sensitive vesicles: characterization and in vitro skin permeation","volume":"19","author":"Carafa","year":"2009","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ajps.2014.01.001","article-title":"Novel chemical permeation enhancer for transdermal drug delivery","volume":"9","author":"Chen","year":"2014","journal-title":"Asian J Pharm Sci."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0035","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1351\/PAC-CON-08-11-01","article-title":"Basic ionic liquids based on monoquaternized 1,4-diazobicyclo[2. 2. 2]octane (DABCO) and dicyanamide anion: physicochemical and solvent properties","volume":"81","author":"Chiappe","year":"2009","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0040","series-title":"Transdermal dosage forms: drug delivery to the blood stream, in Remington education pharmaceutics","first-page":"431","author":"Fox Shelley Chambers","year":"2014"},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0045","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1246\/bcsj.80.2262","article-title":"Ionic liquids then and now: from solvents to materials to active pharmaceutical ingredients","volume":"80","author":"Hough","year":"2007","journal-title":"Bull. Chem. Soc. Jpn."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0050","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1039\/b706677p","article-title":"The third evolution of ionic liquids: active pharmaceutical ingredients","volume":"31","author":"Hough","year":"2007","journal-title":"New J. Chem."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0055","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ijpharm.2008.01.034","article-title":"Water-immiscible room temperature ionic liquids (RTILs) as drug reservoirs for controlled release","volume":"354","author":"Jaitely","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/108076803762718079","article-title":"A collaborative evaluation of the cytotoxicity of two surfactants by using the human corneal epithelial cell line and the WST-1 test","volume":"19","author":"Huthala","year":"2003","journal-title":"J. Ocular Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2013.02.040","article-title":"Skin penetration enhancers","volume":"447","author":"Lane","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijpharm.2016.11.020_bib0070","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1208\/s12249-008-9062-8","article-title":"Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system","volume":"9","author":"Limpongsa","year":"2008","journal-title":"AAPS PharmScTech."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0075","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1134\/S207020511404011X","article-title":"Aggregation Behavior Anticorrosion Effect, and Antimicrobial Activity of Alkylmethylmorpholinium Bromides","volume":"50","author":"Mirgorodskaya","year":"2014","journal-title":"Protection of Metals and Physical Chemistry of Surfaces"},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0080","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejps.2008.01.002","article-title":"Room temperature ionic liquids and their mixtures: potential pharmaceutical solvents","volume":"33","author":"Mizuuchi","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0085","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1021\/mp300441c","article-title":"Effect of chemical permeation enhancers on stratum corneum barrier lipid organizational structure and interferon alpha permeability","volume":"10","author":"Moghadam","year":"2013","journal-title":"Mol. Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0090","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijpharm.2010.08.034","article-title":"Ionic liquid-in-oil microemulsion as a potential carrier of sparingly soluble drug: characterization and cytotoxicity evaluation","volume":"400","author":"Moniruzzaman","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0095","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1039\/b907462g","article-title":"Ionic liquid-assisted transdermal delivery of sparingly soluble drugs","volume":"46","author":"Moniruzzaman","year":"2010","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0100","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000154927","article-title":"Skin permeation and distribution of two sunscreens: a comparison between reconstituted human skin and hairless rat sin","volume":"21","author":"Monti","year":"2008","journal-title":"Skin Pharmacol Physiol."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/ics.12199","article-title":"4-Methylbenzydene camphor microspheres: reconstituted epidermis (Skinethic() permeation and distribution","volume":"37","author":"Monti","year":"2015","journal-title":"Int. J. Cosm. Sci"},{"issue":"8","key":"10.1016\/j.ijpharm.2016.11.020_bib0110","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/jps.24028","article-title":"opical formulations containing finasteride. Part I: in vitro permeation\/penetration study and in vivo pharmacokinetics in hairless rat","volume":"103","author":"Monti","year":"2014","journal-title":"J Pharm Sci."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0115","series-title":"Test Guideline 428: Skin Absorption: in vitro Method","author":"OECD","year":"2004"},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0120","series-title":"OECD Series on Testing and Assessment Number 28","article-title":"Guidance Document for the Conduct of Skin Absorption Studies","author":"OECD","year":"2004"},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0125","doi-asserted-by":"crossref","DOI":"10.4172\/2329-9053.1000113","article-title":"Role of surfactants as penetration enhancer in transdermal drug delivery system","volume":"2","author":"Pandey","year":"2014","journal-title":"J. Mol. Pharm. Org. Process Res."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.colsurfb.2015.01.044","article-title":"Self-assembling systems based on quaternized derivatives of 1,4-diazabicyclo[2. 2. 2]octane in nutrient broth as antimicrobialagents and carriers for hydrophobic drugs","volume":"127","author":"Pashirova","year":"2015","journal-title":"Colloids and Surf B Biointerfaces"},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0135","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1039\/b207543c","article-title":"Anti-microbial activities of ionic liquids","volume":"5","author":"Pernak","year":"2003","journal-title":"Green Chem."},{"issue":"4","key":"10.1016\/j.ijpharm.2016.11.020_bib0140","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.ecoenv.2010.10.032","article-title":"Acute toxicity and biodegradability of N-alkyl-N-methylmorpholinium and N-alkyl-DABCO based ionic liquids","volume":"74","author":"Pretti","year":"2011","journal-title":"Ecotoxicol Environ Saf."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0145","doi-asserted-by":"crossref","first-page":"9228","DOI":"10.1039\/C4CC02021A","article-title":"Ionic liquids for energy, materials, and medicine","volume":"50","author":"Smiglak","year":"2014","journal-title":"Chem Commun."},{"issue":"3","key":"10.1016\/j.ijpharm.2016.11.020_bib0150","first-page":"645","article-title":"Preparation of diltiazem base from official salt form and its characterization","volume":"2","author":"Venkateswara Reddy","year":"2014","journal-title":"Int J. Med Pharm Res."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0155","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1023\/A:1007648807195","article-title":"Drug distribution in human skin using two different in vitro test systems: comparison with in vivo data","volume":"17","author":"Wagner","year":"2000","journal-title":"Pharm Res."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0160","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.0022-202x.2001.01688.x","article-title":"Human skin penetration of flufenamic acid: in vivo\/in vitro correlation (deeper skin layers) for skin samples from the same subject","volume":"118","author":"Wagner","year":"2002","journal-title":"J. Invest Dermatol."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0165","series-title":"Structures and Interactions of ionic liquids","first-page":"39","article-title":"Aggregation in systems of ionic liquids","author":"Wang","year":"2014"},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0170","doi-asserted-by":"crossref","first-page":"7955","DOI":"10.1021\/ie070678o","article-title":"Transesterification of cottonseed oil catalyzed by Br\u00f8nsted acidic ionic liquids","volume":"46","author":"Wu","year":"2007","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.ijpharm.2016.11.020_bib0175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molstruc.2012.02.061","article-title":"Syntheses and properties of a series of novel surface active salts based on 1,4-dialkyl-1,4-diazoniabicyclo[2. 2. 2]octane and their supermolecular interactions with cucurbituril., 2012 uril","volume":"1017","author":"Xu","year":"2012","journal-title":"J. of Mol. Struct."},{"issue":"5","key":"10.1016\/j.ijpharm.2016.11.020_bib0180","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1134\/S0023158413050200","article-title":"Supramolecular Catalytic Systems Based on Alkylated Diquaternary 1 4-Diazabicyclo[2.2.2]octane Derivatives","volume":"54","author":"Zhil\u2019tsova","year":"2013","journal-title":"Kinetics and Catalysis"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316310729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517316310729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T22:25:46Z","timestamp":1536272746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517316310729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0378517316310729"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.11.020","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ionic liquids as potential enhancers for transdermal drug delivery","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2016.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}